Description
Flixotide (fluticasone propionate) is a respiratory medications and inhalers agent listed in our Respiratory medications and inhalers directory and prescribed for specified asthma or reversible-airway conditions (1.1) (2.1). Administered via the respiratory (inhalation) route, Flixotide is available for delivery to U.S. residents through Canadian Pharmacy Store with a valid prescription. Review the clinical fact table, dosage directions, cautions, drug interactions, side effects, and official regulatory sources below.
Flixotide is a medication containing the active pharmaceutical ingredient fluticasone propionate, classified pharmacologically as a respiratory medications and inhalers agent (2.1). It is clinically indicated for the management of specified asthma or reversible-airway conditions as part of a comprehensive treatment plan supervised by a licensed healthcare provider (2.1).
Within the Respiratory medications and inhalers section of our catalogue, patients and prescribers frequently review Flixotide alongside related therapies such as Advair (Fluticasone Propionate / Salmeterol Xinafoate), Advair Diskus (Fluticasone Propionate / Salmeterol Xinafoate), Flonase (Fluticasone Propionate), and Flovent (Fluticasone Propionate).
Official Indications and Usage
Fluticasone Propionate Diskus is indicated for the maintenance treatment of asthma as prophylactic therapy in patients aged 4 years and older.
Limitations of use: Fluticasone Propionate Diskus is not indicated for the relief of acute bronchospasm. Important limitation: Not indicated for relief of acute bronchospasm. (1.1)
Mechanism of Action and Pharmacology
Fluticasone propionate is a synthetic trifluorinated corticosteroid with anti-inflammatory activity. Fluticasone propionate has been shown in vitro to exhibit a binding affinity for the human glucocorticoid receptor that is 18 times that of dexamethasone, almost twice that of beclomethasone-17-monopropionate (bmp), the active metabolite of beclomethasone dipropionate, and over 3 times that of budesonide. Data from the McKenzie vasoconstrictor assay in man are consistent with these results. The clinical significance of these findings is unknown. Inflammation is an important component in the pathogenesis of asthma. (1.1) (1.1)
What is Asthma?
Asthma involves inflammation and narrowing of the airways. Controller and quick-relief treatments have distinct roles in an individualized action plan. Explore related medications below and discuss treatment options with your healthcare provider. Read our complete Asthma condition guide for appointment questions and related therapies (3.1).
Ordering Flixotide from Canada for U.S. Delivery
U.S. patients can order Flixotide (Fluticasone) in U.S. dollars with a valid prescription from a U.S.-licensed clinician. Your card is only charged after your prescription passes pharmacist safety checks and is ready to ship.
Step 1
Send Your Prescription
- Valid Rx required from a U.S.-licensed physician, NP, or PA (Rx rules).
- Upload Rx online, request a pharmacy transfer, or have your doctor fax (844) 666 – 6819.
- Order up to a 90-day personal-use supply per shipment (refill planning).
Step 2
Pharmacist Safety Check
- Multi-point dosing and interaction review completed in under 1 business day.
- Mandatory licensed pharmacist consultation via phone, voicemail, or text before dispatch.
- Verified under our Pharmacy Safety Standards.
Step 3
$14.99 USD Tracked Parcel
- Packed in discreet protective packaging for a flat $14.99 USD per order ($29.99 if combined with cold-chain).
- Tracked via Canada Post and USPS: 3 to 7 business days from Canada (7 to 14 days from international partners).
- Review full shipping and delivery details.
Step 4
U.S. Street Delivery & Payment
- Delivered to any physical U.S. street address with signature upon delivery (no P.O. Boxes).
- You see and approve the country of origin upfront before your card is charged.
- Report any delayed or damaged parcel within 48 hours for prompt resolution.
Fact Table
| Clinical Specification | Details |
|---|---|
| Brand / Product Name | Flixotide |
| Chemical / Generic Name | Fluticasone Propionate |
| Pharmacological Class | Respiratory medications and inhalers agent |
| Therapeutic Category | Respiratory medications and inhalers |
| Same-Ingredient Catalogue Entries | Advair (Fluticasone Propionate / Salmeterol Xinafoate), Advair Diskus (Fluticasone Propionate / Salmeterol Xinafoate), Flonase (Fluticasone Propionate), Flovent (Fluticasone Propionate) |
| Molecular Formula | C25H31F3O5S (2.1) |
| Molecular Weight | 500.6 g/mol (2.1) |
| Bioavailability | ~1% (1.1) |
| Elimination Half-Life | ~7.8 hours (1.1) |
| Legal Status | Rx-Only (Prescription Required) |
| Regulatory Reference Authorities | U.S. FDA (DailyMed), Health Canada (DPD), NIH PubChem, NLM MedlinePlus |
| Routes of Administration | Respiratory (Inhalation) |
| Dosage Forms & Strengths | Inhalation powder: Inhaler containing a foil blister strip of powder formulation for oral inhalation. The strip contains fluticasone propionate 50, 100 |
| Primary Indications | Specified Asthma Or Reversible-Airway Conditions |
| Pregnancy & Breastfeeding | Consult Doctor / Prescriber before use |
| PubChem CID | 444036 |
| FDA UNII Identifier | O2GMZ0LF5W |
| NLM RxNorm Concept ID (RxCUI) | 896018, 896021, 896025 |
| FDA Application License | NDA020833 |
| Official DailyMed SetID | 348cbd8c-edeb-499c-961d-3aeb5cc2cef1 |
| Catalogue Index Links | Letter F Index · All Medications · All Categories |
Directions
Dosage and Administration Overview
For oral inhalation only. Starting dosage is based on prior asthma therapy and disease severity. Treatment of asthma in patients aged 12 years and older: 100 mcg twice daily up to a maximum recommended dosage of 1,000 mcg twice daily. (1.1)
Presentations and Strengths
Inhalation powder: Inhaler containing a foil blister strip of powder formulation for oral inhalation. The strip contains fluticasone propionate 50, 100, or 250 mcg per blister. Inhalation powder: Inhaler containing fluticasone propionate (50, 100, or 250 mcg) as a powder formulation for oral inhalation. (1.1)
Administration Guidance
Administer Flixotide strictly via the prescribed inhalation device according to the schedule set by your healthcare provider (1.1). Prime, load, inhale, and clean the inhaler exactly as shown in the manufacturer’s patient leaflet. If using an inhaled corticosteroid preparation, rinse your mouth with water and spit out after each dose when directed to reduce local throat irritation.
Missed Dose Guidance
If you miss a scheduled dose of Flixotide, follow the missed-dose instructions in the official patient leaflet or ask your pharmacist. Do not double the next dose to make up for a missed dose (2.1).
Ingredients
Active Pharmaceutical Ingredient
The active ingredient in Flixotide is fluticasone propionate (molecular formula C25H31F3O5S, molecular weight 500.6 g/mol) (2.1) (2.1). Other catalogue entries containing fluticasone propionate include Advair (Fluticasone Propionate / Salmeterol Xinafoate), Advair Diskus (Fluticasone Propionate / Salmeterol Xinafoate), Flonase (Fluticasone Propionate), and Flovent (Fluticasone Propionate).
Excipients and Formulation Carriers
Film coatings, stabilizers, and inactive carriers vary by strength and manufacturer presentation. If you have a known allergy to lactose, dyes, sulfites, or specific preservatives, ask our pharmacist to check the exact excipient list for your selected package (2.1).
Cautions and important safety information
Contraindications
The use of Fluticasone Propionate Diskus is contraindicated in the following conditions: Primary treatment of status asthmaticus or other acute episodes of asthma where intensive measures are required Severe hypersensitivity to milk proteins or demonstrated hypersensitivity to fluticasone propionate Primary treatment of status asthmaticus or acute episodes of asthma requiring intensive measures. (1.1)
Key Clinical Precautions
Before starting or continuing Flixotide, discuss your complete medical history with your healthcare provider. Key clinical cautions include (1.1):
- Increased susceptibility to infection: Therapies that modulate immune or metabolic pathways can increase the risk of bacterial, mycotic (fungal), viral, or opportunistic infections. Report fever, persistent cough, painful urination, or localized infection promptly.
- Hypersensitivity and anaphylaxis: Serious allergic reactions, including anaphylaxis, angioedema, and severe rash, have been reported. Discontinue use and seek immediate medical care if swelling of the face, lips, tongue, or throat or difficulty breathing occurs.
- Angioedema: Swelling of the face, extremities, lips, tongue, glottis, or larynx can occur at any time during treatment. Airway-involving angioedema requires emergency medical intervention.
- Hypotension and volume depletion: Intravascular volume contraction can cause symptomatic low blood pressure, orthostatic dizziness, or fainting, especially in older adults, patients with impaired renal function, or those taking diuretics. Ensure adequate hydration before and during therapy.
- Discontinuation and withdrawal effects: Do not abruptly stop taking this medication without consulting your prescriber. Premature discontinuation or abrupt withdrawal can cause rebound symptoms, disease flare, or increased thrombotic or cardiovascular risk depending on the drug class.
Pregnancy, Lactation, and Special Populations
There are insufficient data on the use of fluticasone propionate Diskus in pregnant women. There are clinical considerations with the use of fluticasone propionate Diskus in pregnant women. In animals, teratogenicity characteristic of corticosteroids, decreased fetal body weight, and/or skeletal variations in rats, mice, and rabbits were observed with subcutaneously administered maternal toxic doses of fluticasone propionate less than the maximum recommended human daily inhaled dose (mrhdid) on a mcg/m 2 basis. (1.1)
Interactions
Official Drug Interaction Overview
Strong cytochrome P450 3A4 inhibitors (e.g., ritonavir, ketoconazole): Use not recommended. May increase risk of systemic corticosteroid effects. (1.1)
Important Interaction Categories
Concomitant use of Flixotide with certain prescription medications, over-the-counter drugs, or supplements can alter how the medication works or increase the risk of side effects. Important interaction categories to review with your prescriber and pharmacist include (2.1):
- Strong CYP3A4 inhibitors and inducers (such as ketoconazole, itraconazole, clarithromycin, ritonavir, rifampin, carbamazepine, phenytoin, or St. John’s wort): Co-administration with strong CYP3A4 inhibitors can significantly increase plasma concentrations and side-effect risk, whereas CYP3A4 inducers can decrease systemic exposure and reduce efficacy.
Side effects
Like all medications, Flixotide can cause side effects, although not everyone experiences them. Commonly reported side effects in clinical trials and official labeling include (1.1):
- Nausea (feeling sick): Often mild to moderate and most noticeable when starting therapy or increasing the dose; eating smaller, lower-fat meals and avoiding lying down immediately after eating may help reduce nausea.
- Vomiting: Persistent vomiting that prevents fluid intake should be reported to your clinician to prevent dehydration.
- Headache: Commonly reported during initial treatment; often improves as your body adjusts to the medication.
- Dizziness or lightheadedness: May occur especially when standing up quickly from a sitting or lying position (orthostatic changes); rise slowly and stay well hydrated.
- Fatigue or tiredness: May occur during initial adjustment or dose changes.
- Skin rash: Mild skin eruptions can occur; seek immediate care if a rash blisters, peels, or is accompanied by fever.
Clinical Trial and Postmarketing Adverse Reactions
Systemic and local corticosteroid use may result in the following: Candida albicans infection Immunosuppression Hypercorticism and adrenal suppression Reduction in bone mineral density Growth effects Glaucoma and cataracts Most common adverse reactions (incidence >3%) include upper respiratory tract infection or inflammation, throat irritation, sinusitis, rhinitis, oral candidiasis, nausea and vomiting, gastrointestinal discomfort, fever, cough, bronchitis, and headache. Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared with rates in the clinical trials of another drug and may not reflect the rates observed in practice. (1.1)
When to Seek Immediate Medical Attention
Contact your physician or seek urgent medical care if you experience signs of a severe allergic reaction (hives, difficulty breathing, or swelling of the face, lips, tongue, or throat), severe dizziness or fainting, unexplained severe pain, or any sudden change in your clinical symptoms (2.1).
Storage and handling
Fluticasone Propionate Diskus 50 mcg is supplied as a disposable orange plastic inhaler containing a foil blister strip with 60 blisters. The inhaler is packaged in a plastic-coated, moisture-protective foil pouch (NDC 85766-235-60 relabeled from NDC 66993-790-97). (1.1)
Store Flixotide in its original container at controlled room temperature away from excess heat, direct light, and moisture (such as bathroom cabinets), and keep out of reach of children and pets (1.1).
What is a generic drug?
A generic medication contains the exact same active pharmaceutical ingredient (fluticasone propionate) as its brand-name counterpart and is formulated to deliver the same dosage strength, route of administration, safety profile, quality, and therapeutic performance (2.1). Regulatory authorities require generic manufacturers to demonstrate bioequivalence, meaning the generic medication releases its active ingredient into the bloodstream at virtually the same rate and to the same extent as the innovator brand.
While a generic tablet, capsule, or inhaler may differ in color, shape, scoring, or packaging due to trademark laws that govern brand appearance, its clinical mechanism and active ingredient match the reference medicine. Because generic manufacturers do not repeat the initial discovery and multi-phase clinical trial investments of the original brand, generic equivalents offer substantial cost savings for patients paying out of pocket.
Canadian Pharmacy Store delivers prescription and over-the-counter medications to U.S. residents. Browse our Respiratory medications and inhalers directory, explore all medications A-Z, review how ordering works and prescription requirements, or call 1-888-868-1920 for personal assistance matching your prescription.
Related Medications in Our Catalogue
- Advair (Fluticasone Propionate / Salmeterol Xinafoate), listed in Respiratory medications and inhalers
- Advair Diskus (Fluticasone Propionate / Salmeterol Xinafoate), listed in Respiratory medications and inhalers
- Flonase (Fluticasone Propionate), listed in Allergy medications
- Flovent (Fluticasone Propionate), listed in Respiratory medications and inhalers
- Aermony RespiClick PD (Fluticasone Propionate), listed in Respiratory medications and inhalers
- Acetylcysteine, listed in Respiratory medications and inhalers
Related Categories, Directories, and Ordering Guides
- Respiratory medications and inhalers Category Directory
- Medications Starting with F
- Active Ingredient Directory
- What to prepare before a prescription order
- How to compare prescription prices without mixing up the product
- How to Order Prescription Medication
- Prescription Requirements
- Ordering Medication from Canada Guide
- Caregiver Ordering Guide
- Explore Medications
- Explore Categories
- Explore Allergy
Frequently Asked Questions About Flixotide
What is Flixotide and what active ingredient does it contain?
Flixotide is a respiratory medications and inhalers agent containing the active pharmaceutical ingredient fluticasone propionate (chemical formula C25H31F3O5S). It is supplied for respiratory (inhalation) administration and requires a valid prescription where applicable.
How does Flixotide work in the body?
Fluticasone propionate is a synthetic trifluorinated corticosteroid with anti-inflammatory activity. Fluticasone propionate has been shown in vitro to exhibit a binding affinity for the human glucocorticoid receptor that is 18 times that of dexamethasone, almost twice that of beclomethasone-17-monopropionate (bmp), the active metabolite of beclomethasone dipropionate, and over 3 times that of budesonide. Data from the McKenzie vasoconstrictor assay in man are consistent with these results.
What conditions is Flixotide prescribed to treat?
Flixotide is primarily indicated for specified asthma or reversible-airway conditions. Your prescribing clinician determines the appropriate indication, strength, and treatment duration based on your individual diagnosis and medical history.
How should I take or use Flixotide?
Follow the exact dosage, frequency, and administration instructions printed on your prescription label. Flixotide is administered via the respiratory (inhalation) route. Inhale or administer it consistently at the same time(s) as directed, and never adjust your dose or stop therapy without speaking with your prescriber.
What are the most common side effects of Flixotide?
Commonly reported side effects of Flixotide include feeling sick, vomiting, headache, dizziness, tiredness, and rash. Most mild side effects improve as your body adjusts to treatment, but you should notify your doctor or pharmacist if symptoms persist or worsen.
What medications or substances can interact with Flixotide?
Important interaction categories for Flixotide include medicines that strongly affect CYP3A enzymes. Always share a complete list of your prescription drugs, over-the-counter medicines, vitamins, and herbal supplements with your pharmacist before starting treatment.
Can Flixotide be used during pregnancy or breastfeeding?
If you are pregnant, planning to become pregnant, or breastfeeding, consult your prescribing physician before using Flixotide to weigh the clinical benefits and potential risks.
Do I need a prescription to buy Flixotide online from Canada?
Yes. A valid prescription written by a U.S.-licensed physician, nurse practitioner, or physician assistant is required to buy Flixotide (Fluticasone) through our licensed Canadian pharmacy partners. Valid prescriptions go through multiple safety checks in less than 1 business day, followed by a mandatory request to speak with a licensed pharmacist for a consultation (watch your phone, voicemails, and text messages).
Does Flixotide have a generic equivalent (Fluticasone) at a Canada pharmacy?
Yes. A lower-cost generic equivalent (Fluticasone Furoate, Fluticasone Propionate) containing Fluticasone is available alongside brand-name Flixotide in our Canada pharmacy catalogue.
Other Brands: AERMONY RESPICLICK PD, Arnuity, Avamys, Cutivate, Flonase, Flovent, VeramystGeneric: Fluticasone Furoate, Fluticasone Propionate
How is Flixotide shipped to U.S. residents, and how much does shipping cost?
Flixotide ships in discreet protective packaging at a flat rate of $14.99 USD per order via Canada Post and USPS with full tracking (if combined in the same order with a cold-chain item, total shipping is $29.99 USD in a larger container). Once your valid prescription passes safety checks (<1 business day) and you respond to the mandatory licensed pharmacist consultation request via phone, voicemail, or text message, delivery takes 3 to 7 business days from Manitoba, Canada (or 7 to 14 business days from licensed partner pharmacies in the UK, Singapore, and Mauritius). You see and choose the country of origin before you pay, and your Visa, Mastercard, or Discover card is only charged when your order is ready to ship.
How can I send or transfer my Flixotide prescription, or ask about an unlisted strength?
You can upload a clear photo or PDF of your Flixotide prescription online, request a prescription transfer or direct prescriber coordination from our team, or have your prescriber fax the prescription directly to (844) 666 – 6819. You may order up to a 90-day personal-use supply per shipment. If you do not see your exact prescribed strength or manufacturer listed, call 1-888-868-1920 and our staff will check availability across our licensed pharmacy partners.
References & Official Sources
Clinical, pharmacological, and safety facts for Flixotide (Fluticasone Propionate) are compiled directly from official regulatory prescribing labels and primary biomedical databases:
- (1.1) Flixotide (Fluticasone Propionate), Official Prescribing Information. U.S. National Library of Medicine / U.S. Food and Drug Administration (DailyMed). Official U.S. FDA / DailyMed Structured Product Labeling (SPL). (Accessed 2026-10-29).
- (2.1) PubChem Compound Summary for cid 444036 (Fluticasone Propionate). National Center for Biotechnology Information (NCBI), U.S. National Library of Medicine. Official regulatory & clinical reference. (Accessed 2026-10-29).
- (3.1) MedlinePlus Medical Encyclopedia: Asthma. MedlinePlus / National Library of Medicine. U.S. National Library of Medicine, MedlinePlus Drug & Health Information. (Accessed 2026-10-29).
- (4.1) Health Canada Drug Product Database (DPD), Authorized Product Records. Health Canada / Government of Canada. Health Canada Drug Product Database & Official Product Monograph. (Accessed 2026-10-29).
